Naprosyn and Astigmatism - a phase IV clinical study of FDA data

Summary:

Astigmatism is reported as a side effect among people who take Naprosyn (naproxen), especially for people who are male, 60+ old, also take Aredia, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Astigmatism when taking Naprosyn. It is created by eHealthMe based on reports of 16,337 people who have side effects when taking Naprosyn from the FDA, and is updated regularly.

What is Naprosyn?

Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 16,738 Naprosyn users. Check the latest studies of Naprosyn.

What is Astigmatism?

Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina) is found to be associated with 374 drugs and 414 conditions by eHealthMe. Check the latest studies of Astigmatism.

On Jul, 10, 2026

16,337 people reported to have side effects when taking Naprosyn.
Among them, 41 people (0.25%) have Astigmatism.

Among these 41 people:

What is the gender of people who have Astigmatism when taking Naprosyn? *

female: 9.76 %
male: 90.24 %

What is the age of people who have Astigmatism when taking Naprosyn? *

What are other drugs people take besides Naprosyn? *

What are other side effects people have besides Astigmatism? *

Stress And Anxiety: 39 people, 95.12%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 38 people, 92.68%
General Physical Health Deterioration (weak health status): 38 people, 92.68%
Dyspnea (difficult or laboured breathing): 38 people, 92.68%
Glaucoma (increased fluid pressure in the eye with vision loss): 37 people, 90.24%
Osteonecrosis Of Jaw (death of bone of jaw): 37 people, 90.24%
Decreased Interest: 37 people, 90.24%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 34 people, 82.93%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 33 people, 80.49%
Sleep Disorder: 32 people, 78.05%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 27 people, 65.85%
Nausea (feeling of having an urge to vomit): 9 people, 21.95%
Pulmonary Congestion (congestion in the lungs): 1 person, 2.44%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 2.44%
Osteoporosis (bones weak and more likely to break): 1 person, 2.44%
Neoplasm Malignant (cancer tumour): 1 person, 2.44%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 2.44%
Impaired Gastric Emptying: 1 person, 2.44%
Cough: 1 person, 2.44%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 2.44%

* Approximation only. Some reports may have incomplete information.

Do you take Naprosyn and have Astigmatism?

- Check whether Astigmatism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Naprosyn:

Naprosyn (16,738 reports)

Astigmatism treatments and more:

Astigmatism (2,086 reports)

Browse all side effects of Naprosyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Astigmatism:

Astigmatism (374 drugs)

Browse all the conditions that are associated with Astigmatism:

Astigmatism (414 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on naproxen (the active ingredients of Naprosyn) and Naprosyn (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.